Antioxidant Nano-Targeted Therapeutics For Oxidative Stress Management in CVS

Abstract

Oxidative stress functions as a primary disease mechanism which leads to cardiovascular system disorders that affect the entire cardiovascular system through atherosclerosis and myocardial infarction and ischemia-reperfusion injury and heart failure. The body experiences excessive reactive oxygen species (ROS) production which causes cells to lose their redox balance, resulting in lipid peroxidation and protein changes and endothelial cell damage and mitochondrial dysfunction. Conventional antioxidants exhibit limited clinical effectiveness because they suffer from low bioavailability and fast metabolism and their active ingredients spread throughout the body without targeting specific areas. The implementation of nanotechnology-based delivery systems creates a new therapeutic method which enables precise and continuous delivery of antioxidants to specific body regions. Nano formulations consist of polymeric nanoparticles and liposomes and dendrimers and metal-organic frameworks which can protect both natural and synthetic antioxidants by wrapping them in protective shells that prevent degradation while improving their pharmacological effects. The targeted delivery strategies which use ligand-modified nanoparticles to reach both endothelial receptors and ischemic myocardium enable doctors to deliver treatments with greater accuracy while reducing the potential for adverse effects that affect the entire body. The application of stimuli-responsive Nano carriers which respond to pH changes and redox potential fluctuations and enzymatic activity enables researchers to regulate their delivery of contents within oxidative microenvironments. Preclinical studies show that Nano-targeted antioxidant treatments provide better heart protection and lower oxidative damage markers and better heart muscle recovery results when compared to standard treatment methods. The development of commercial products faces three fundamental obstacles which include difficulties in producing large quantities of the product as well as assessing its safety over extended periods and obtaining regulatory approval for its use in medical settings. Antioxidant Nano-targeted therapeutics provide a revolutionary approach to treat oxidative stress problems which exist in cardiovascular systems because these therapies show experimental success but need more testing before they can be used in medical settings.